Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
No abstract available
Article activity feed
-
SciScore for 10.1101/2020.04.06.20055475: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Human samples: The 26 COVID-19 patients enrolled in the study were provided written informed consent. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Single-cell sorting by flow cytometry: For B cell enrichment, PBMCs were firstly stained with FITC-conjugated anti-CD19 antibody (Biolegend) on ice for 30 min. anti-CD19suggested: NonePE-conjugated anti-CD20 antibody (Biolegend), anti-CD20suggested: NoneAPC-Cy7-conjugated anti-CD3 antibody (Biolegend), anti-CD3suggested: Noneanti-CD14 antibody (Biolegend), anti-C…SciScore for 10.1101/2020.04.06.20055475: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement Consent: Human samples: The 26 COVID-19 patients enrolled in the study were provided written informed consent. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Single-cell sorting by flow cytometry: For B cell enrichment, PBMCs were firstly stained with FITC-conjugated anti-CD19 antibody (Biolegend) on ice for 30 min. anti-CD19suggested: NonePE-conjugated anti-CD20 antibody (Biolegend), anti-CD20suggested: NoneAPC-Cy7-conjugated anti-CD3 antibody (Biolegend), anti-CD3suggested: Noneanti-CD14 antibody (Biolegend), anti-CD14suggested: Noneanti-CD56 antibody (Biolegend) and APC-Cy7-conjugated LIVE/DEAD dye (Life Technologies). anti-CD56suggested: NoneAfter washing with PBST, the bound antibodies were incubated with anti-human IgG HRP detection antibody (Bioss Biotech) for 30 min, followed by washed with PBST, then PBS and addition of TMB (Beyotime). anti-human IgGsuggested: NoneThen, the incubated mixtures were added to ELISA plates and allowed to develop for 30 min, followed by PBST washing and anti-mouse Fc HRP antibody (Thermo Fisher Scientific). anti-mouse Fc HRPsuggested: NoneExperimental Models: Cell Lines Sentences Resources The digested heavy and light chain genes were further cloned into human IgG1 heavy chain and light chain expression vectors, respectively. Transfection: Human embryonic kidney (HEK) 293T cells of 80-90% confluent in the 15 cm tissue culture plate were transfected with master mixture containing 9 μg heavy chain plasmid, 9 μg light chain plasmid and 60 μl HEKsuggested: NoneThen, the mixtures were incubated with 10,000 hACE2-plasmid transiently transfected 293T cells for 40 min on ice, followed by stained with Alexa Fluor 647-conjugated goat anti-mouse IgG (Biolegend) and APC-Cy7-conjugated LIVE/DEAD dye (Life Technologies). 293Tsuggested: NoneConcisely, HEK-293T cells were transfected with psPAX2, pLenti-GFP and 2019-nCov S plasmids by using TransIT-293 Transfection reagent (Mirus). HEK-293Tsuggested: NoneAt 40 hours-post incubation, the luciferase activity of infected hACE2/293T cells were detected by Dual-Luciferase Reporter Assay System ( hACE2/293Tsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
-